Edwards Lifesciences Corporation (NYSE:EW - Get Free Report) VP Daniel Lippis sold 619 shares of the business's stock in a transaction that occurred on Tuesday, November 10th. The shares were sold at an average price of $104.25, for a total value of $64,530.75. Following the transaction, the vice president directly owned 40,034 shares in the company, valued at approximately $4,173,544.50. This represents a 1.52% decrease in their position. The t…